This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Finck, B. N. Articles by Kelly, D. P. Search for Related Content PubMed PubMed Citation Articles by Finck, B. N. Articles by Kelly, D. P. Related Collections Animal models of human disease Energy metabolism Genetically altered mice Physiological and pathological control of gene expression Myocardial cardiomyopathy disease

(Circulation. 2007;115:2540-2548.)
© 2007 American Heart Association, Inc.

Basic Science for Clinicians

Peroxisome Proliferator–Activated Receptor Coactivator-1 (PGC-1) Regulatory Cascade in Cardiac Physiology and Disease

Brian N. Finck, PhD; Daniel P. Kelly, MD

From the Centers for Human Nutrition (B.N.F.) and Cardiovascular Research (B.N.F., D.P.K.) and Departments of Medicine (B.N.F., D.P.K.), Molecular Biology and Pharmacology (D.P.K.), and Pediatrics (D.P.K.), Washington University School of Medicine, St Louis, Mo.

Correspondence to Daniel P. Kelly, MD, Washington University School of Medicine, 660 S Euclid Ave, Campus Box 8086, St. Louis, MO 63110. E-mail dkelly@im.wustl.edu

Key Words: cardiomyopathy • cardiovascular diseases • diabetes mellitus • fatty acids • genes • glucose • metabolism

An extract of the first 250 words of the full text is provided, because this article has no abstract.

	Introduction

 
The constant workload of the heart requires a high-capacity mitochondrial system to match ATP production with functional demands. In the adult mammalian heart, ATP synthesis occurs primarily through complete oxidation of fatty acids and glucose in the mitochondrion. Mitochondrial metabolic pathways are exquisitely regulated at many levels. Mitochondrial oxidative flux is modulated by concentrations of substrates and metabolite intermediates and by posttranslational modification of enzymes catalyzing key, rate-limiting reactions. Importantly, the capacity for mitochondrial oxidative energy metabolism also is regulated at the level of gene transcription. The present review summarizes recent work that defines the role of a transcriptional coactivator, peroxisome proliferator–activated receptor coactivator-1 (PGC-1), as a master regulator of myocardial energy metabolism in diverse physiological and pathophysiological conditions.

	Mitochondrial Fatty Acid and Glucose Utilization Pathways

 
The mitochondrion is an efficient ATP synthesis machine that rapidly converts energy stored in fatty acids, glucose, and lactate into high-energy phosphates, which provide the fuel driving contractile function, ion homeostasis, and other cellular processes within the cardiac myocyte. Fatty acids enter the mitochondrion intact and are catabolized in the mitochondrial fatty acid ß-oxidation spiral. Oxidation of fatty acids in this pathway produces reducing equivalents (NADH and FADH₂) and acetyl-CoA, a 2-carbon molecule that can enter the tricarboxylic acid cycle for further oxidation (Figure 1). For glucose to enter the oxidative pathways of the mitochondrion, it must first undergo anaerobic metabolism in the cytosol of the cardiac myocyte and be converted to pyruvate (Figure 1). This 3-carbon intermediate can then be converted to lactate outside . . . [Full Text of this Article]

This article has been cited by other articles:

				H. Bugger, M. Schwarzer, D. Chen, A. Schrepper, P. A. Amorim, M. Schoepe, T. D. Nguyen, F. W. Mohr, O. Khalimonchuk, B. C. Weimer, et al. Proteomic remodelling of mitochondrial oxidative pathways in pressure overload-induced heart failure Cardiovasc Res, November 11, 2009; (2009) cvp344v2. [Abstract] [Full Text] [PDF]

				Z. Lu, I. Scott, B. R. Webster, and M. N. Sack The Emerging Characterization of Lysine Residue Deacetylation on the Modulation of Mitochondrial Function and Cardiovascular Biology Circ. Res., October 23, 2009; 105(9): 830 - 841. [Abstract] [Full Text] [PDF]

				Y. Nakagawa, K. Kuwahara, G. Takemura, M. Akao, M. Kato, Y. Arai, M. Takano, M. Harada, M. Murakami, M. Nakanishi, et al. p300 Plays a Critical Role in Maintaining Cardiac Mitochondrial Function and Cell Survival in Postnatal Hearts Circ. Res., October 9, 2009; 105(8): 746 - 754. [Abstract] [Full Text] [PDF]

				J. Gutkowska, T. L. Broderick, D. Bogdan, D. Wang, J.-M. Lavoie, and M. Jankowski Downregulation of oxytocin and natriuretic peptides in diabetes: possible implications in cardiomyopathy J. Physiol., October 1, 2009; 587(19): 4725 - 4736. [Abstract] [Full Text] [PDF]

				J. W. Gordon, C. Pagiatakis, J. Salma, M. Du, J. J. Andreucci, J. Zhao, G. Hou, R. L. Perry, Q. Dan, D. Courtman, et al. Protein Kinase A-regulated Assembly of a MEF2{middle dot}HDAC4 Repressor Complex Controls c-Jun Expression in Vascular Smooth Muscle Cells J. Biol. Chem., July 10, 2009; 284(28): 19027 - 19042. [Abstract] [Full Text] [PDF]

				A. Garnier, J. Zoll, D. Fortin, B. N'Guessan, F. Lefebvre, B. Geny, B. Mettauer, V. Veksler, and R. Ventura-Clapier Control by Circulating Factors of Mitochondrial Function and Transcription Cascade in Heart Failure: A Role for Endothelin-1 and Angiotensin II Circ Heart Fail, July 1, 2009; 2(4): 342 - 350. [Abstract] [Full Text] [PDF]

				C. Pellieux, C. Montessuit, I. Papageorgiou, and R. Lerch Angiotensin II downregulates the fatty acid oxidation pathway in adult rat cardiomyocytes via release of tumour necrosis factor-{alpha} Cardiovasc Res, May 1, 2009; 82(2): 341 - 350. [Abstract] [Full Text] [PDF]

				X. Palomer, D. Alvarez-Guardia, R. Rodriguez-Calvo, T. Coll, J. C. Laguna, M. M. Davidson, T. O. Chan, A. M. Feldman, and M. Vazquez-Carrera TNF-{alpha} reduces PGC-1{alpha} expression through NF-{kappa}B and p38 MAPK leading to increased glucose oxidation in a human cardiac cell model Cardiovasc Res, March 1, 2009; 81(4): 703 - 712. [Abstract] [Full Text] [PDF]

				S. Gundewar, J. W. Calvert, S. Jha, I. Toedt-Pingel, S. Yong Ji, D. Nunez, A. Ramachandran, M. Anaya-Cisneros, R. Tian, and D. J. Lefer Activation of AMP-Activated Protein Kinase by Metformin Improves Left Ventricular Function and Survival in Heart Failure Circ. Res., February 13, 2009; 104(3): 403 - 411. [Abstract] [Full Text] [PDF]

				R. Ventura-Clapier, A. Garnier, and V. Veksler Transcriptional control of mitochondrial biogenesis: the central role of PGC-1{alpha} Cardiovasc Res, July 15, 2008; 79(2): 208 - 217. [Abstract] [Full Text] [PDF]

				G. D. Lopaschuk and D. P. Kelly Signalling in cardiac metabolism Cardiovasc Res, July 15, 2008; 79(2): 205 - 207. [Full Text] [PDF]

				J.-a Kim, Y. Wei, and J. R. Sowers Role of Mitochondrial Dysfunction in Insulin Resistance Circ. Res., February 29, 2008; 102(4): 401 - 414. [Abstract] [Full Text] [PDF]

				D. M. Thomson, S. T. Herway, N. Fillmore, H. Kim, J. D. Brown, J. R. Barrow, and W. W. Winder AMP-activated protein kinase phosphorylates transcription factors of the CREB family J Appl Physiol, February 1, 2008; 104(2): 429 - 438. [Abstract] [Full Text] [PDF]

				M. Zungu, M. P. Alcolea, F. J. Garcia-Palmer, M. E. Young, and M. F. Essop Genomic modulation of mitochondrial respiratory genes in the hypertrophied heart reflects adaptive changes in mitochondrial and contractile function Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H2819 - H2825. [Abstract] [Full Text] [PDF]